Breaking: Avanci launches EV Charger patent licensing programme
The offering is the company’s sixth new platform of 2023
The offering is the company’s sixth new platform of 2023
As Nokia awaits decision on India’s FRAND-setting proposal, company tells IAM the Chongqing judgement shows Oppo “has an obligation to pay”
Dell is another new licensee while on the patent holder side, BlackBerry has joined HEVC Advance. Does it show HEVC is spreading and the pool landscape has consolidated?
The new pan-EU court has already shaken up the European patent landscape
01 December 2023
Court rulings reveal risks for SEP holders who fail to communicate pre-litigation, explaining why 80% of SEP suits we studied alleged pre-suit offers to engage in licensing negotiations
28 November 2023
The agreement grants the companies use of each other’s patents in 4G and 5G standards
27 November 2023
The High Court of Justice has expedited the FRAND trial in proceedings brought by Panasonic against Xiaomi and Oppo. In this case, the judge directed that the FRAND trial will come first and will occur in just under a year. Despite Panasonic’s objection, the judge deemed that there would be enough time to prepare for the trial.
24 November 2023
Andrew Yen chats to IAM about pool participation, selling patents and the European SEP policy proposal
24 November 2023
IAM Connect: Patent Policy and Litigation delved deeply into Section 101 legislation, reform efforts at the Patent Trial and Appeal Board, and reactions to the European Commission's SEP proposal
23 November 2023
HP becomes latest SEP implementer to be targeted at the Unified Patent Court
22 November 2023
A wide range of EU legislators are voicing powerful and articulate opposition to the policy proposal
20 November 2023
Public comments by the implementer and SEP holder camps show the ideological dividing lines that the USPTO, NIST, and International Trade Association need to navigate
16 November 2023
When companies with the innovation and tech leadership credentials of Ericsson, Nokia and Novo Nordisk raise major concerns about Commission proposals, their arguments deserve serious consideration. But it’s not happening. No wonder Europe is losing the global competition race
15 November 2023
Unlock unlimited access to all IAM content